SB-0860 Summary

• Defines "opioid antagonist" as naloxone hydrochloride or FDA-approved equivalents, and "opioid-related overdose" as conditions including respiratory depression, coma, or death resulting from opioid consumption.

• Allows prescribers and pharmacists to dispense opioid antagonists to individuals at risk of overdose, family members, friends, or organizations acting under prescriber direction without charge.

• Requires the Department of Health to publish an annual report by February 1 documenting opioid-related overdose fatalities, trends, patterns, risk factors, and effective interventions in Michigan.

• Provides civil liability protection for prescribers and pharmacists who properly store and dispense opioid antagonists under this authorization.

• Authorizes electronically transmitted prescriptions under HIPAA compliance and allows pharmacists to modify certain prescription details with prescriber consultation.